Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays

This publication has 36 references indexed in Scilit:

• Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
  Journal of Clinical Oncology, 2009
• Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib
  Clinical Cancer Research, 2009
• Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: Correlation with clinical parameters and outcome
  European Journal Of Cancer, 2009
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression
  Cancer, 2007
• Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients
  Melanoma Research, 2006
• Expression of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptors 1 and 2 in Melanoma
  Clinical Cancer Research, 2006
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions
  Cancer, 2002
• Human Melanoma Cells but Not Normal Melanocytes Express Vascular Endothelial Growth Factor Receptors
  Biochemical and Biophysical Research Communications, 1993